- Home
- / Arix Bioscience
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Arix Bioscience financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
£112 K
FY, 2022
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|---|---|
| Revenue | 1.3M | 506.0K | 477.0K | 340.0K | 112.0K |
| Gross profit | 1.3M | 506.0K | 477.0K | 340.0K | 112.0K |
| Gross profit margin, % | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating expense total | 14.5M | 12.1M | 7.5M | 4.6M | 5.2M |
| Depreciation and amortization | 503.0K | 1.7M | 500.0K | 209.0K | 229.0K |
| EBITDA | (13.2M) | (11.5M) | (7.0M) | (4.3M) | (5.1M) |
| EBITDA margin, % | -994.0% | -2282.0% | -1462.9% | -1251.2% | -4521.4% |
| EBIT | (13.7M) | (13.3M) | (7.5M) | (6.0M) | (5.3M) |
| EBIT margin, % | -1031.9% | -2619.0% | -1567.7% | -1750.9% | -4725.9% |
| Interest income | 720.0K | 769.0K | 101.0K | 156.0K | 1.6M |
| Interest expense | 12.0K | ||||
| Pre tax profit | 42.8M | (75.6M) | 126.3M | (61.1M) | (27.6M) |
| Income tax expense | 5.9M | (5.9M) | (4.0K) | ||
| Net Income | 36.9M | (69.7M) | 126.3M | (61.1M) | (27.6M) |